Thomas Murray

January 4, 2023: This Week’s COVID-19 Grand Rounds Will Share Long COVID Outcome Data From the COVID-OUT Trial

Posted on by Damon Seils

Headshots of Dr. Carolyn Bramante and Dr. Thomas MurrayIn this Friday’s COVID-19 Grand Rounds, Dr. Carolyn Bramante and Dr. Thomas Murray of the University of Minnesota will present “Outpatient Treatment of COVID-19 With Metformin, Ivermectin, or Fluvoxamine: 10-Month Follow-up and Effects on Developing Long COVID.”

The Grand Rounds session will be held on Friday, January 6, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.

July 6, 2022: Grand Rounds to Spotlight COVID-OUT Trial of Metformin, Ivermectin, and Fluvoxamine

Posted on by Damon Seils
Headshots of Drs. Carolyn Bramante, Thomas Murray, Jared Huling
Left to right: Dr. Carolyn Bramante, Dr. Thomas Murray, Dr. Jared Huling

In this Friday’s COVID-19 Grand Rounds, Dr. Carolyn Bramante, Dr. Thomas Murray, and Dr. Jared Huling of the University of Minnesota will present “Results From the COVID-OUT Trial, a Phase-3 Trial of Outpatient Treatment for COVID-19 Using Metformin, Ivermectin, and Fluvoxamine.”

The Grand Rounds session will be held on Friday, July 8, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.

September 29, 2021: COVID-19 Grand Rounds to Feature COVID-OUT Trial of Outpatient Treatments

Posted on by Damon Seils
Headshots of Drs. Carolyn Bramante, Thomas Murray, Jared Huling
Left to right: Dr. Carolyn Bramante, Dr. Thomas Murray, and Dr. Jared Huling

In this Friday’s COVID-19 Grand Rounds session, Dr. Carolyn Bramante, Dr. Thomas Murray, and Dr. Jared Huling of the University of Minnesota will present “COVID-OUT: From Computer Modeling to a Phase III Trial of Early Outpatient Treatment for SARS-CoV-2 Infection.” COVID-OUT is a factorial randomized clinical trial of metformin, ivermectin, fluvoxamine, or a combination of these medications among outpatients with symptoms of COVID-19 or long COVID.

The Grand Rounds session will be held on Friday, October 1, at 1:00 pm eastern. Join the online meeting.

The NIH Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency.

For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.